16:46 IST
BSE
Other Announcement
Brawn Biotech Other Announcement
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
Brawn Biotech Ltd
- Share price
- ₹25.50
- Market cap
- ₹7.65 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 8.9×Sector 47.3×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Other Announcement 3Board Meeting Date 2Debt & Borrowing 1Annual General Meeting 1
Time
3 announcements with these filters
16:20 IST
BSE
Other Announcement
Brawn Biotech Other Announcement
Brawn Biotech Ltd notified BSE regarding the non-applicability of Regulation 24A for Annual Secretarial Compliance Report. The company remains below the mandatory reporting thresholds for capital and networth.
16:57 IST
BSE
Other Announcement
Brawn Biotech Other Announcement
Brawn Biotech Ltd submitted the compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The Registrar, RCMC Share Registry, confirmed that security certificates received for dematerialisation were processed and mutilated within the required 15-day period.